NIH: Adding Weekly GLP-1 to Cognitive Behavioral Therapy Further Reduces Heavy Drinking
May 02, 2026
May 02, 2026
WASHINGTON, May 2 (TNSjou) -- The U.S. Department of Health and Human Services' National Institutes of Health issued the following news release:
* * *
Adding weekly GLP-1 to cognitive behavioral therapy further reduces heavy drinking
Clinical trial suggests semaglutide may help patients with alcohol use disorder and obesity.
*
A team of National Institutes of Health (NIH) scientists and international colleagues have reported t . . .
* * *
Adding weekly GLP-1 to cognitive behavioral therapy further reduces heavy drinking
Clinical trial suggests semaglutide may help patients with alcohol use disorder and obesity.
*
A team of National Institutes of Health (NIH) scientists and international colleagues have reported t . . .